Appeals Court Rejects Novo Nordisk Challenge to Medicare Drug...

shared a link

2025-10-07 15:00:06

Appeals Court Rejects Novo Nordisk Challenge to Medicare Drug Pricing Plan

Flags with the logo of Novo Nordisk, the maker of Ozempic and Wegovy, in a file image. Mads Claus Rasmussen/Ritzau Scanpix/AFP via Getty ImagesA federal appeals court on Oct. 6 rejected a challenge from

0 Comments 0 Shares 7 Views